Cargando…
Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System
The present study develops on insulin-release studies from the chitosan-amide-modified stimuli-responsive polymers formed from various fatty acids including stearic acid, oleic acid, linoleic acid, and linolenic acid. This is the continuation of an earlier reported study that investigates the insuli...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689140/ https://www.ncbi.nlm.nih.gov/pubmed/36354609 http://dx.doi.org/10.3390/gels8110701 |
_version_ | 1784836453757353984 |
---|---|
author | Dahan, Wasmia Mohammed Mohammad, Faruq Ezzat, AbdelRahman O. Atta, Ayman M. Al-Tilasi, Hissah Hamad Al-Lohedan, Hamad A. |
author_facet | Dahan, Wasmia Mohammed Mohammad, Faruq Ezzat, AbdelRahman O. Atta, Ayman M. Al-Tilasi, Hissah Hamad Al-Lohedan, Hamad A. |
author_sort | Dahan, Wasmia Mohammed |
collection | PubMed |
description | The present study develops on insulin-release studies from the chitosan-amide-modified stimuli-responsive polymers formed from various fatty acids including stearic acid, oleic acid, linoleic acid, and linolenic acid. This is the continuation of an earlier reported study that investigates the insulin-release profiles of chitosan-modified fatty acid amides (without stimuli responsive polymers). Following the synthesis and characterization of many different fatty acid amides with a varying amount of unsaturation, the insulin drug loading and release effects were compared among N-isopropylacrylamide (NIPAm), a thermo-responsive polymer, and 2-acrylamide-2-methylpropane sulfonic acid (AMPS), a pH-responsive polymer-modified hydrogel that is expected to enhance environmental response and the controllability of release. Finally, drug release effects were studied to investigate the drug release mechanisms with the help of five different pharmacokinetic models including the zero-order, first-order, Higuchi, Korsmeyers–Peppas, and Hixson models. The results indicate that the Higuchi and Hixson models are valid in terms of the operation of the NIPAm and AMPS matrices during the delivery of insulin. |
format | Online Article Text |
id | pubmed-9689140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96891402022-11-25 Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System Dahan, Wasmia Mohammed Mohammad, Faruq Ezzat, AbdelRahman O. Atta, Ayman M. Al-Tilasi, Hissah Hamad Al-Lohedan, Hamad A. Gels Article The present study develops on insulin-release studies from the chitosan-amide-modified stimuli-responsive polymers formed from various fatty acids including stearic acid, oleic acid, linoleic acid, and linolenic acid. This is the continuation of an earlier reported study that investigates the insulin-release profiles of chitosan-modified fatty acid amides (without stimuli responsive polymers). Following the synthesis and characterization of many different fatty acid amides with a varying amount of unsaturation, the insulin drug loading and release effects were compared among N-isopropylacrylamide (NIPAm), a thermo-responsive polymer, and 2-acrylamide-2-methylpropane sulfonic acid (AMPS), a pH-responsive polymer-modified hydrogel that is expected to enhance environmental response and the controllability of release. Finally, drug release effects were studied to investigate the drug release mechanisms with the help of five different pharmacokinetic models including the zero-order, first-order, Higuchi, Korsmeyers–Peppas, and Hixson models. The results indicate that the Higuchi and Hixson models are valid in terms of the operation of the NIPAm and AMPS matrices during the delivery of insulin. MDPI 2022-10-30 /pmc/articles/PMC9689140/ /pubmed/36354609 http://dx.doi.org/10.3390/gels8110701 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dahan, Wasmia Mohammed Mohammad, Faruq Ezzat, AbdelRahman O. Atta, Ayman M. Al-Tilasi, Hissah Hamad Al-Lohedan, Hamad A. Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title | Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title_full | Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title_fullStr | Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title_full_unstemmed | Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title_short | Enhanced Delivery of Insulin through Acrylamide-Modified Chitosan Containing Smart Carrier System |
title_sort | enhanced delivery of insulin through acrylamide-modified chitosan containing smart carrier system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689140/ https://www.ncbi.nlm.nih.gov/pubmed/36354609 http://dx.doi.org/10.3390/gels8110701 |
work_keys_str_mv | AT dahanwasmiamohammed enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem AT mohammadfaruq enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem AT ezzatabdelrahmano enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem AT attaaymanm enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem AT altilasihissahhamad enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem AT allohedanhamada enhanceddeliveryofinsulinthroughacrylamidemodifiedchitosancontainingsmartcarriersystem |